Argenx (Belgium)
Ghent, Belgium
Team details appear once the team leader joins.
Is this your team? Claim it
CIDP (chronic inflammatory demyelinating polyneuropathy)
FollowWhat is new in CIDP (chronic inflammatory demyelinating polyneuropathy) research, which clinical trials are open, and who works on it. From public registries and PubMed, with the source and date of every fact.
Cure status
- ClaseprubartPhase 3 · NCT06858579
- empasiprubartPhase 3 · NCT06920004
- Empasiprubart IVPhase 3 · NCT07091630 · NCT07638566
- Gamunex-CPhase 3 · NCT07540221
- Immune globulin (human) 10% solution for intravenous administrationPhase 3 · NCT06752356
- IVIgPhase 3 · NCT06290141 · NCT06920004
- PanzygaPhase 3 · NCT04929236
- riliprubartPhase 3 · NCT06290141 · NCT06290128
- Riliprubart Prefilled Pen (PFP)Phase 3 · NCT06859099
- ripertamabPhase 3 · NCT06858722
- Rituximab (Mabthera)Phase 3 · NCT06714838
- XembifyPhase 3 · NCT07540221
- NipocalimabPhase 2/3 · NCT05327114
- Anti-Thymocyte GlobulinPhase 2 · NCT00716066
- Autologous Hematopoietic Stem Cell TransplantationPhase 2 · NCT00716066
- CarmustinePhase 2 · NCT00716066
- CytarabinePhase 2 · NCT00716066
- Efgartigimod PH20 SCPhase 2 · NCT04280718
- EtoposidePhase 2 · NCT00716066
- ImeroprubartPhase 2 · NCT07032662
- ImmunoadsorptionPhase 2 · NCT04881682
- ImmunoglobulinsPhase 2 · NCT04881682
- MelphalanPhase 2 · NCT00716066
- Peripheral Blood Stem Cell TransplantationPhase 2 · NCT00716066
- PrednisonePhase 2 · NCT00716066
- Syngeneic Bone Marrow TransplantationPhase 2 · NCT00716066
- Azercabtagene zapreleucel (azer-cel)Phase 1 · NCT06680037
- CyclophosphamidePhase 1 · NCT07304154 · NCT07526493
- FludarabinePhase 1 · NCT07304154 · NCT07526493
- Intravenous immune globulin GPhase 1 · NCT05584631
- KITE-363Phase 1 · NCT07304154
- Subcutaneous immune globulin GPhase 1 · NCT05584631
- Universal CD19 CAR-γδT Cell InjectionPhase 1 · NCT07526493
- CD19/BCMA-targeted CAR-T cellsEarly phase 1 · NCT07337785
- Lymphodepleting ConditioningEarly phase 1 · NCT07337785
Closest to patients
- A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkA Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkJohns Hopkins Hospital- Site Number : 8400015 · Baltimore, United States + 136 more hospitalsPhase 3Results expected 2026
- Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Kobe City Medical Center General Hospital · Kobe, Japan + 118 more hospitalsPhase 2/3Results expected 2026
- Ripertamab for the Treatment of Chronic Inflammatory Demyelinating PolyneuropathyRipertamab for the Treatment of Chronic Inflammatory Demyelinating PolyneuropathyZhongming Qiu (sponsor)Phase 3Results expected 2027
Let us optimize your content
Apply for experimental treatment or a research study
The trial team decides who can take part; your doctor can help you ask.
Distance is calculated in your browser. Your city is not sent to us.
Loading trial sites…
Latest news
Results, new trials and publications, newest first. Every item links to its source.
Results and new studies, newest first, in plain words.
Plain-language summary pending. Original title shown.
Publication
Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles.
Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles.
Journal of neurochemistry
PubMed · PMID 27861905
Find fellow researchers
Groups with active CIDP (chronic inflammatory demyelinating polyneuropathy) work.
Charité – Universitätsmedizin Berlin
Berlin, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
Humboldt-Universität zu Berlin
Berlin, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
Erasmus MC
Rotterdam, Netherlands
Team details appear once the team leader joins.
Is this your team? Claim it
University of Pennsylvania
Philadelphia, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Hospital de Sant Pau
Barcelona, Spain
Team details appear once the team leader joins.
Is this your team? Claim it
Cedars-Sinai Medical Center
Los Angeles, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Freie Universität Berlin
Berlin, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
Ruhr University Bochum
Bochum, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
Medizinische Hochschule Hannover
Hanover, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
University of Minnesota
Minneapolis, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Duke University
Durham, United States
Team details appear once the team leader joins.
Is this your team? Claim it